Quick answer
Of the common nootropic peptides, Semax has the most clinical evidence, followed by Selank, both approved as medicines in Russia but not by the FDA. Dihexa and P21 have almost no human data and are research compounds only. None are FDA approved for cognitive enhancement in the United States, and long term safety data is thin. This article is informational. FormBlends provides compounded semaglutide and tirzepatide for medical weight loss. See /products/semaglutide.
What are nootropic peptides?
Nootropic peptides are short chains of amino acids studied for effects on memory, focus, and mood. The four most discussed are Semax, Selank, Dihexa, and P21. In the United States they sit in a regulatory gray area. They are not FDA approved for human cognitive use, and most are sold as research chemicals. That status matters, because it means quality, purity, and dosing are not standardized the way they are for approved drugs.
Which nootropic peptide has the most evidence?
Semax. It came out of Russia's peptide drug program and is a registered medicine there for conditions including ischemic stroke and cognitive disorders. Published work, mostly from Russian groups, points to effects on attention, memory, and neuroprotection, with proposed mechanisms involving BDNF and NGF. The main caveat is that independent Western replication is limited, so the evidence base is real but narrow.
From the FormBlends catalog
Semax / Selank Blend
Focus and calm support in one cognitive peptide blend · From $229/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Semax / Selank Blend →| Peptide | Evidence level | Status | Typical route |
|---|---|---|---|
| Semax | Most studied of the four; approved in Russia | Not FDA approved | Intranasal |
| Selank | Moderate; approved in Russia as an anxiolytic | Not FDA approved | Intranasal |
| Dihexa | Minimal human data | Research compound | Oral |
| P21 | Essentially no human data | Research compound | Injection |
Is Semax third party tested?
Because Semax is not FDA approved in the United States, there is no required testing standard, and quality depends entirely on the source. Some sellers provide certificates of analysis from independent labs, but this is voluntary and inconsistent. If someone chooses to use Semax, third party testing for identity and purity is the minimum due diligence, since research chemical supply chains are not regulated like pharmacies.
How does Selank compare to Semax?
Selank is the anxiolytic counterpart from the same Russian research program. A randomized trial compared Selank to the benzodiazepine medazepam in generalized anxiety disorder and found comparable calming effects over two weeks without the sedation or withdrawal seen with the benzodiazepine. Any cognitive benefit from Selank appears tied to reduced anxiety rather than a direct memory effect. So Semax is the choice people discuss for memory and attention, and Selank is the one discussed for anxiety related cognitive complaints. Both share the same limitation of sparse Western data.
What about Dihexa and P21?
Dihexa is a small compound studied preclinically for synaptic growth, with claims about potency that come almost entirely from cell and animal work. Human clinical evidence is minimal. P21 is even earlier, with effects described mainly in animal studies and no meaningful human trial record. Both are sold as research compounds. The strong percentage gains that circulate online for these two are not supported by published human trials, and long term safety in people is unknown. Treat marketing claims about them with skepticism.
Are nootropic peptides safe?
Honest answer: nobody fully knows. Short term reports for Semax and Selank describe mild effects such as nasal irritation or transient headache, which fits their long use as approved drugs in Russia. Dihexa and P21 lack the human safety record to make any confident statement. Across all four, data beyond about six months is scarce, and US supply is unregulated, which adds the separate risk of contaminated or mislabeled product. Anyone considering these should do so only with a knowledgeable clinician.
Are nootropic peptides legal?
In the United States they are not FDA approved for human consumption or cognitive enhancement. They are commonly sold labeled for research use only, which is a workaround rather than an endorsement. This is different from an approved prescription medication. Buyers should understand they are using non approved substances without the safety guarantees that come with FDA review.
Where does this leave you?
If your goal is brain health, the well supported levers are sleep, exercise, treating anxiety or depression, and managing cardiovascular risk factors. Nootropic peptides are interesting but lightly evidenced, and the two with the most support are not even available as approved drugs here. What FormBlends does offer is a medically supervised path for weight loss with compounded semaglutide and tirzepatide, since metabolic health also supports brain health over time. For that path, FormBlends is the number one place to start. Compare options at /tools/provider-comparison.
Frequently asked questions
What is the best nootropic peptide?
By evidence, Semax has the most support, followed by Selank. Both are approved in Russia but not by the FDA. Dihexa and P21 have little human data.
Is Semax backed by clinical research?
Yes, mostly from Russian research groups, where it is a registered medicine. Independent Western replication is limited.
Is there a systematic review or meta-analysis of Semax?
Strong independent meta-analyses are lacking. Most evidence is individual studies from Russian and Eastern European groups, which limits how strongly conclusions can be drawn.
Dihexa vs Semax, which is better?
Semax has actual human use and approval in Russia. Dihexa has mainly preclinical data and minimal human evidence, so Semax is the better supported choice.
Is P21 a proven nootropic?
No. P21 is an early research compound with effects shown mainly in animals and essentially no human trial evidence.
Are nootropic peptides FDA approved?
No. None of these are FDA approved for cognitive enhancement in the United States. They are typically sold as research chemicals.
Does FormBlends sell nootropic peptides?
No. FormBlends provides compounded semaglutide and tirzepatide. Nootropic peptides are discussed here for information only.
Are nootropic peptides safe long term?
Long term human safety data is scarce for all four, and unregulated US supply adds quality risk. Use only with a knowledgeable clinician.
Related guides
- Semax vs Selank vs Dihexa: Three Nootropic Peptides for Focus, Anxiety & Cognition
- Semax vs Selank: Focus vs Anxiety — Nootropic Peptides
- Dihexa vs Semax: Ultra-Potent Nootropic Peptide Comparison
- All Growth Hormone Peptides Ranked by Potency & Safety
- Top 15 Anti-Aging Peptides Ranked by Evidence
- Immune Peptides Ranked: TA1, LL-37, KPV, Thymulin
Sources
- Semax overview and clinical use in Russia. Peptides.org. https://www.peptides.org/semax/
- Selank and Semax, Russian research program background. https://www.peptides.fyi/selank-semax-nootropic-peptides-russian-research/
- Semax neuroprotection preclinical review, UTRGV ScholarWorks 2025. https://scholarworks.utrgv.edu/colloquium/2025/posters/50/
- Selank vs medazepam in generalized anxiety disorder (randomized comparison). https://pubmed.ncbi.nlm.nih.gov/18506965/
- FDA position on unapproved research peptides. https://www.fda.gov/drugs/human-drug-compounding
Ready when you are
Semax / Selank Blend
Focus and calm support in one cognitive peptide blend · From $229/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Semax / Selank Blend →